Lexpos News

Class 4 Medicines Defect Information: Methadone 1mg/mL Oral Solution BP – Sugar Free, Methadone Mixture 1mg/ml (Thornton & Ross Ltd) Drug alert number: EL (23)A/07 Date issued: 7 March 2023 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Methadone 1mg/mL Oral Solution BP – Sugar [...]

The post MHRA Class 4 Medicines Defect Information: Methadone 1mg/mL Oral Solution BP – Sugar Free, Methadone Mixture 1mg/ml (Thornton & Ross Ltd) appeared first on PSNC Website.

The Department of Health and Social Care (DHSC) has introduced new pharmaceutical regulations, to take effect on 1 April 2023, to accompany the introduction of the HRT PPC. They are within the  National Health Service (Amendments Relating to Pre-Payment Certificates, Hormone Replacement Therapy Treatments and Medicines Shortages) Regulations 2023. The HRT PPC is a new, [...]

The post New regulations to accompany the introduction of HRT prepayment certificates (HRT PPCs) appeared first on PSNC Website.

Following representations from PSNC, the Department of Health and Social Care (DHSC) has confirmed that the following products have been granted upward retrospective pricing adjustments due to out of date product and/or pricing information held on NHS dictionary of medicines and devices (dm+d): To apply for June 2022 prescriptions: Aptamil® Anti-Reflux powder (800 gram) – [...]

The post Retrospective pricing adjustments for Venofer, Ferinject and Aptamil products appeared first on PSNC Website.

We have now collated the formal nominations submitted from all those standing for election as an Independent regional representative or a non-CCA Multiple representative on PSNC (Community Pharmacy England).  Independent Regional Representative Elections:  In four of the ten PSNC regions more than one valid nomination was received, and a ballot will be held. These regions [...]

The post PSNC Regional Representative and non-CCA Multiple Elections – ballots start 9 March appeared first on PSNC Website.

Drug alert number: EL(23)A/06 Date issued: 2 March 2023 The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 2 medicines recall for: Levothyroxine 12.5mcg Tablets (Teva UK Limited) – PL 00289/1971 Batch Number Expiry Date Pack Size First Distributed 214052 10 2023 28 tablets 20 July 2022 Active Pharmaceutical Ingredients: Levothyroxine Sodium [...]

The post MHRA Class 2 Medicines Recall: Levothyroxine 12.5mcg Tablets (Teva UK Limited) appeared first on PSNC Website.